加州戴维斯.11月. 01, 2021 — Marrone生物创新公司. (纳斯达克:MBII), 可持续生物保护和植物健康解决方案的国际领导者, 已将MBI-306的监管包提交给美国.S. Environmental Protection Agency (EPA) 和 for MBI-206 to all three Brazilian regulatory authorities – the National Health Surveillance Agency (ANVISA), the Ministry of Agriculture (MAPA) 和 the Institute of Environment 和 Renewable Natural 资源 (IBAMA) – paving the way for commercialization of its novel nematicides/insecticides.
在等待EPA批准之前，MBI-306将参与15美元的竞争.70亿全球杀虫剂市场1 和 provide specialty 和 row crop growers with a next-generation technology to control a broad spectrum of yield-robbing insects 和 nematodes, 包括玉米根虫幼虫.
“我们正在按期提交, 正如我们承诺, 和 thus begins the regulatory review process that will allow us to bring two differentiated products with favorable environmental benefits to the world’s largest soybean 和 corn-growing regions,首席执行官凯文Helash说. 这两款产品的最高潜在营收预计都将超过1亿美元, MBI-306 和 its variants 和 MBI-206 will be important contributors to advancing Marrone Bio’s growth 和 leadership in crop bioprotection.”
MBI-206 has been submitted for approval in Brazil for two uses: as a seed treatment 和 as a foliar/in-furrow product. 批准, 该种子处理将用于控制大豆和玉米线虫, which are estimated to be on a record-setting 148 million acres for the 2021/2022 growing season.2
“The expected approval of MBI-206 in Brazil is a significant step forward for MBI as we look to grow our global footprint with strategic partners in South America. The seed treatment 和 foliar product are great examples of how we are aggressively building a global portfolio of biological products 和 positioning them in markets that will provide the greatest impact for growers 和 MBI alike,”Helash补充说.
MBI-306和MBI-206是在一种专利微生物(伯克rinojensis strain A396) that has been the active ingredient in MBI’s 崇敬® bioinsecticide 和 Majestene® bionematicide products. 这两款产品预计将于2023/2024年上市.
Marrone生物创新公司. (纳斯达克:MBII) is a growth-oriented agricultural company leading the movement to environmentally sustainable farming practices through the discovery, 创新生物保护产品的开发和销售, bte365官网在线投健康和bte365官网在线投营养. Our portfolio of 18 products helps customers operate more sustainably while increasing their return on investment. The company’s commercial products are sold globally 和 supported by a robust portfolio of more than 500 issued 和 pending patents. Our end markets include row crops; fruits 和 vegetables; trees, nuts 和 vines; 和 greenhouse production. Marrone Bio’s research 和 development program uses proprietary technologies to isolate 和 screen naturally occurring microorganisms 和 plant extracts to create new, 农业中的环保解决方案.
This press release contains forward-looking statements within the meaning of the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. 前瞻性陈述涉及重大风险和不确定性. 所有的报表, 除了陈述历史事实外, 包括在本新闻稿关于战略, 未来运作及计划, 包括这些陈述背后的假设, 是前瞻性陈述, 并且不应被认为代表了公司的任何后续日期的观点. Examples of such statements include financial guidance 和 other statements regarding the company’s future revenue growth, 利润率, 营业费用, 和 other financial results; adoption of the company’s products; 和 the potential benefits 和 value of the company’s products. Such forward-looking statements are based on information available to the company as of the date of this release 和 involve a number of risks 和 uncertainties, 有些超出了公司的控制, that could cause actual results to differ materially from those anticipated by these forward-looking statements, including the recent uncertainty in the global economy 和 industry-specific economy caused by the COVID-19 p和emic, 消费者, 影响公司产品需求的监管和其他因素, any difficulty in exp和ing the company’s sales 和 marketing infrastructure or marketing the company’s products in global markets, 虫害治理产品的市场竞争, 客户和种植者对生物害虫管理产品缺乏了解, 分销商的不良行为, 制造商, regulatory agencies 和 other relevant third parties 和 costs associated with any strategic acquisitions or other business opportunities we elect to pursue. Additional information that could lead to material changes in the company’s performance is contained in its filings with the Securities 和 Exchange Commission. 公司没有义务, 并明确声明对, 更新或改变本版本中包含的前瞻性声明, 是否是新信息的结果, 未来事件或其他.